Allopurinol
Product Images NDC 53002-4820

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 53002-4820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

R:\regulatory\spl\jennifer\allopurinol\allopurinol10032017\allopurinol-01.jpg (Allopurinol 01)

Chemical structure of Allopurinol, showing its molecular framework with nitrogen atoms in a bicyclic purine analog ring system including ketone and amine groups.*

FDA Label Image

R:\regulatory\spl\jennifer\allopurinol\allopurinol10032017\allopurinol-02.jpg (Allopurinol 02)

Chemical structure diagram depicting the interconversion between Allopurinol, Oxipurinol, Hypoxanthine, Xanthine, and Uric Acid, showing molecular structures and key compound names involved in purine metabolism.*

FDA Label Image

Label Image (Lbl530024820)

Label for Allopurinol 300 mg tablets by RPK Pharmaceuticals, Inc. The label indicates a quantity of 30 tablets per bottle with instructions to take 1 tablet daily or as directed. It includes barcodes, lot numbers, and placeholders for patient and clinic names, with storage directions and prescription-only status noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.